US-based Masimo has received CE Mark clearance for the iSpO2 Rx pulse oximeter for Android and iOS devices for medical use in select countries.
The clearance will help clinicians have access to Masimo SET measure-through-motion and low-perfusion pulse oximetry.
iSpO2 Rx is currently available outside the US and provides accurate spot-check and short-term assessment of oxygen saturation (iSpO2), pulse rate (PR), and perfusion index (PI).
It is suitable for emergency clinicians who want the convenience and availability of pulse oximetry at times when other Masimo handheld oximetry solutions may not be available; as well as for those on the move who require convenient and portable solutions.
The company said that patients under the care of a physician for chronic obstructive pulmonary diseases (COPD) such as emphysema, chronic bronchitis, and bronchiectasis, may benefit from the use of a pulse oximeter for spot checks.
Pulse oximetry is also suitable for patients under the care of a physician, who may use it to evaluate the severity of their asthma attack to help determine if a doctor or emergency room visit is needed.
iSpO2 Rx comes with an integrated finger pulse oximetry sensor or an optional M-LNCS connector, which enables the product to be used with more than 20 Masimo SET pulse oximetry sensors.
The product uses the same Masimo SET measure-through-motion and low-perfusion pulse oximetry technology, which is proven by more than 100 independent and objective studies and used on more than 100 million patients a year in top hospitals worldwide.
Masimo SET pulse oximetry has been shown to have helped clinicians in reducing ventilator weaning time and arterial blood gas measurements in the ICU, as well as saving lives and reducing costs, while decreasing rapid response activations and ICU transfers on the general floor.
In order to ensure that clinicians have the latest mobile medical technologies at all times, iSpO2 Rx is avaiable for select tablet and smartphones, with a downloadable and upgradeable iSpO2 Rx app.
Image: CE Mark clearance will help clinicians to have access of Masimo SET measure-through-motion and low-perfusion pulse oximetry. Photo: courtesy of Masimo.